BlackRock’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$425M Sell
1,762,659
-259,061
-13% -$62.5M 0.01% 1155
2025
Q1
$492M Buy
2,021,720
+10,071
+0.5% +$2.45M 0.01% 1046
2024
Q4
$661M Buy
2,011,649
+81,748
+4% +$26.9M 0.01% 891
2024
Q3
$646M Buy
1,929,901
+379,332
+24% +$127M 0.01% 890
2024
Q2
$423M Buy
1,550,569
+70,665
+5% +$19.3M 0.01% 1108
2024
Q1
$512M Buy
1,479,904
+13,640
+0.9% +$4.72M 0.01% 1011
2023
Q4
$473M Buy
1,466,264
+29,576
+2% +$9.55M 0.01% 1046
2023
Q3
$515M Sell
1,436,688
-141,084
-9% -$50.6M 0.01% 876
2023
Q2
$598M Sell
1,577,772
-20,832
-1% -$7.9M 0.02% 813
2023
Q1
$766M Buy
1,598,604
+16,216
+1% +$7.77M 0.02% 649
2022
Q4
$665M Sell
1,582,388
-3,727
-0.2% -$1.57M 0.02% 706
2022
Q3
$662M Sell
1,586,115
-4,582
-0.3% -$1.91M 0.02% 661
2022
Q2
$787M Sell
1,590,697
-169,429
-10% -$83.9M 0.03% 599
2022
Q1
$991M Sell
1,760,126
-7,955
-0.4% -$4.48M 0.03% 584
2021
Q4
$1.34B Buy
1,768,081
+14,150
+0.8% +$10.7M 0.03% 485
2021
Q3
$1.31B Sell
1,753,931
-85,136
-5% -$63.5M 0.04% 479
2021
Q2
$1.18B Sell
1,839,067
-71,816
-4% -$46.3M 0.03% 523
2021
Q1
$1.09B Buy
1,910,883
+18,547
+1% +$10.6M 0.03% 540
2020
Q4
$1.1B Buy
1,892,336
+270,107
+17% +$157M 0.04% 479
2020
Q3
$836M Buy
1,622,229
+39,908
+3% +$20.6M 0.03% 521
2020
Q2
$714M Sell
1,582,321
-652,890
-29% -$295M 0.03% 536
2020
Q1
$784M Sell
2,235,211
-83,841
-4% -$29.4M 0.04% 443
2019
Q4
$858M Buy
2,319,052
+219,935
+10% +$81.4M 0.03% 522
2019
Q3
$698M Buy
2,099,117
+148,312
+8% +$49.3M 0.03% 562
2019
Q2
$610M Buy
1,950,805
+22,263
+1% +$6.96M 0.03% 640
2019
Q1
$590M Sell
1,928,542
-7,466
-0.4% -$2.28M 0.03% 632
2018
Q4
$450M Buy
1,936,008
+68,124
+4% +$15.8M 0.02% 712
2018
Q3
$585M Buy
1,867,884
+6,197
+0.3% +$1.94M 0.03% 664
2018
Q2
$537M Buy
1,861,687
+30,465
+2% +$8.79M 0.02% 686
2018
Q1
$458M Buy
1,831,222
+54,512
+3% +$13.6M 0.02% 753
2017
Q4
$424M Buy
1,776,710
+85,176
+5% +$20.3M 0.02% 802
2017
Q3
$376M Sell
1,691,534
-46,897
-3% -$10.4M 0.02% 846
2017
Q2
$393M Buy
1,738,431
+5,320
+0.3% +$1.2M 0.02% 783
2017
Q1
$345M Buy
1,733,111
+1,715,872
+9,953% +$342M 0.02% 866
2016
Q4
$3.14M Sell
17,239
-168
-1% -$30.6K ﹤0.01% 1049
2016
Q3
$2.85M Buy
17,407
+2,671
+18% +$438K ﹤0.01% 1060
2016
Q2
$2.11M Sell
14,736
-8,459
-36% -$1.21M ﹤0.01% 1122
2016
Q1
$3.17M Buy
23,195
+1,821
+9% +$249K 0.01% 929
2015
Q4
$2.96M Sell
21,374
-5,202
-20% -$721K ﹤0.01% 957
2015
Q3
$3.57M Buy
26,576
+7,503
+39% +$1.01M 0.01% 860
2015
Q2
$2.87M Buy
19,073
+11,983
+169% +$1.81M ﹤0.01% 981
2015
Q1
$958K Buy
7,090
+6,106
+621% +$825K ﹤0.01% 1338
2014
Q4
$118K Hold
984
﹤0.01% 1649
2014
Q3
$111K Hold
984
﹤0.01% 1641
2014
Q2
$117K Sell
984
-521
-35% -$61.9K ﹤0.01% 1632
2014
Q1
$193K Sell
1,505
-1,323
-47% -$170K ﹤0.01% 1539
2013
Q4
$349K Buy
2,828
+14
+0.5% +$1.73K ﹤0.01% 1424
2013
Q3
$331K Buy
2,814
+61
+2% +$7.18K ﹤0.01% 1344
2013
Q2
$309K Buy
+2,753
New +$309K ﹤0.01% 1352